Viread (Haemato Pharm)
The parallel distributor has informed its supplied customers in a letter dated June 2, 2015, that the affected batch A229473D is being recalled due to a falsification of the packaging. The marketing authorization holder "Gilead Sciences International Limited" was notified by another parallel distributor of an anomaly on the packaging of batch A229473D, which was subsequently identified as a counterfeit. To date, no tampering with the tablets has been detected.
The affected batch A229473D, which was originally produced by "Gilead Sciences International Limited" for Greece and Cyprus, was marketed in Austria by "HAEMATO PHARM GmbH" as parallel distribution. It is requested that when checking inventory, please note that batch A229473D has HAEMATO identification 19-506812 and 19-505709 at the end.
| Name of the medicinal product | Viread 245 mg Filmtabletten |
|---|---|
| Marketing authorisation number(s) | EU/1/01/200/001 |
| Marketing authorisation holder | Gilead Sciences International Limited Paralleldistribution: HAEMATO PHARM GmbH |
| Batch number(s) | A229473D (HAEMATO Identifikation 19-506812) A229473D (HAEMATO Identifikation 19-505709) |
| Classification of the recall | 1 |
| BASG reference number | INS - 640.001 - 1418 |
